Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effectiveness of allogeneic CD3AK cells on transplanted human renal cell cancer in mice with severe combined immune deficiency.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology - 1 Jan 2000

Ge Lei, Shan Zhongjie, Han Qianhe, Zhang Nan, Zhao Yang

Abstract excerpt

PURPOSE: To assess the activity of allogeneic anti-CD3 antibody induced activated killer (CD3AK) cells on transplanted human renal cell cancer (RCC) in mice with severe combined immune deficiency (SCID), thus to provide theoretical and experimental support for clinical application of allogeneic CD3AK cells in the treatment of RCC. METHODS: A culture system which can massively increase allogeneic CD3AK cells was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Renal Cell
Share to CD3 Complex

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytotoxicity, Immunologic

Share to Immunotherapy, Adoptive

Share to Mice, SCID

Share to Transplantation, Homologous

Share to Tumor Burden

Share to Xenograft Model Antitumor Assays

Source

Identifiers

PMID: 27273950

Genes

CCK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effectiveness of allogeneic CD3AK cells on transplanted human renal cell cancer in mice with severe combined immune deficiency.PMID 27273950Read ↗

Autologous CIK cell immunotherapy in patients with renal cell carcinoma after radical nephrectomy.Semantic proximity Read ↗

Application of Highly Immunocompromised Mice for Establishment of Patient-Derived Xenograft (PDX) ModelSemantic proximity Read ↗

Characterization of the Xeno-GVHD Response Generated by Lung Cancer Patient PBMCs in NSG-SGM3 MiceSemantic proximity Read ↗

Nonviral mcDNA-Mediated Cospecific CAR T Cells For The Treatment of Human Hepatocellular Carcinoma Xenograft in MiceSemantic proximity Read ↗

Impaired Lymphocytes Development and Xenotransplantation of Gastrointestinal Tumor Cells in Prkdc-Null SCID Zebrafish Model.Semantic proximity Read ↗

The Immunostimulative Effect and Mechanisms of a Novel Mouse Anti-Human PD-1 Monoclonal Antibody on Jurkat Lymphocytic Cells Cocultured with Hepatoma CellsSemantic proximity Read ↗

Differences in Tumor Growth and Differentiation in NSG and Humanized-BLT Mice; Analysis of Human vs. Humanized-BLT-Derived NK Expansion and FunctionsSemantic proximity Read ↗

Phase I Study of Autologous Tumor Vaccines Transduced with the GM-CSF Gene in Four Patients with Stage IV Renal Cell Cancer in Japan: Clinical and Immunological FindingsSemantic proximity Read ↗

Acute graft-versus-host-like disease induced by transplantation of human activated natural killer cells into SCID mice.Semantic proximity Read ↗

NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cellsSemantic proximity Read ↗

A novel EGFP-expressing nude mice with complete loss of lymphocytes and NK cells to study tumor-host interactions.Semantic proximity Read ↗

Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.